Is compounded tirzepatide still available anywhere legitimate?

Short answer: No — at least in the U.S., “compounded” tirzepatide is not a legitimate or FDA‑approved option and the FDA has warned consumers and pharmacies about it. The only legitimate sources are the approved brand products from the manufacturer.

Key points and what to do

• The only FDA‑approved tirzepatide products are the brand formulations made and distributed by Eli Lilly (Mounjaro for type 2 diabetes; Zepbound for prescription chronic weight management). These are supplied through licensed pharmacies and specialty pharmacy channels.
• The FDA has issued warnings about pharmacies compounding tirzepatide (and other peptides/biologics). Compounded versions may be illegal, untested, contaminated, mislabeled, or incorrectly dosed and have led to enforcement actions. Buying compounded tirzepatide from unverified online sellers or overseas sources is risky.
• If you want tirzepatide, see a licensed clinician (primary care, endocrinologist, weight‑management specialist) who can decide whether a prescription is appropriate and write one for the brand product. Fill that prescription at a licensed pharmacy (local chain or accredited specialty pharmacy) or through the manufacturer’s patient support program.
• If you’re offered “compounded” tirzepatide online or by a compounding pharmacy, verify with your state board of pharmacy and the FDA guidance before proceeding — and avoid it unless a trusted regulator explicitly permits it in your country.

Alternatives and help

• Discuss Mounjaro or Zepbound with your clinician. If tirzepatide isn’t suitable/available, other approved GLP‑1/weight‑loss medications (for example, semaglutide — Wegovy or Ozempic) may be options.
• If you have trouble accessing the brand product, ask your prescriber about manufacturer patient assistance or a specialty pharmacy that handles biologic shipments.

If you’d like, tell me your country or whether you meant an online overseas source and I can give more specific regulatory/availability guidance or point to the FDA/state board resources.